Sex-Specific Effects of GLP-1R Variants on BMI and Obesity Treatment Response
This study identifies sex-specific genetic effects of GLP-1R variants on BMI, noting stronger associations in men but a potential link between the coding variant rs1042044 and weight loss success in women following bariatric surgery, despite a lack of observed functional differences in cellular models.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Obesity is a complex condition where the body stores too much fat, and for decades, the primary ways to treat it have been lifestyle changes or surgery. In recent years, a new class of medicines has emerged that works by mimicking natural hormones called incretins. These hormones are released by the gut after we eat and help regulate blood sugar and appetite. Drugs based on these hormones, such as semaglutide and tirzepatide, have shown remarkable success in helping people lose significant weight. However, not everyone responds to these treatments in the same way; some people lose a great deal of weight, while others see only modest results. Scientists have long suspected that a person's genetic makeup plays a role in this variation, but it has remained unclear whether these genetic factors affect men and women differently. Understanding these differences is crucial because if a specific gene variant influences how well a treatment works for one sex but not the other, doctors could potentially tailor therapies to be more effective for each individual.
A team of researchers set out to investigate this question by looking closely at the genes responsible for the body's incretin system. They focused on five specific genes: GIP, GIP-R, GCG, GCG-R, and GLP-1R. These genes provide the instructions for making the hormones and the receptors that receive their signals. The researchers began by analyzing massive amounts of genetic data from a global study on body mass index, separating the results for men and women to see if any genetic variants had a different impact depending on sex. They discovered that nine specific variations in the GLP-1R gene appeared to have a stronger effect on body mass index in men than in women. Among these nine, only one, known as rs1042044, involved a change in the actual protein structure, swapping one building block for another at a specific spot in the receptor.
To see if this genetic finding mattered in a real-world medical setting, the team examined a group of 807 adults who had undergone bariatric surgery, a procedure that alters the stomach to induce weight loss. They checked the patients' DNA to see if those carrying the specific genetic variant lost more or less weight than those who did not. The data showed a slight, unconfirmed hint that the variant might be linked to weight loss success in women, particularly those who lost more than ten percent of their body weight. However, this link was not strong enough to be considered a definitive discovery after accounting for the many statistical tests performed. The researchers also looked at a group of children and adolescents with severe obesity to find any rare, potentially harmful mutations in these genes, identifying several new variants, though most were found in very few people.
The study then moved from observing people to testing the biology directly in a laboratory. The researchers created a cellular model to see if the genetic change found in the men (the swap of one building block for another in the GLP-1R protein) actually altered how the receptor worked. They tested whether this mutated receptor behaved differently from the normal one when exposed to natural hormones or the drug semaglutide. The results were clear: the mutated receptor functioned just like the normal one. It absorbed the signals and moved within the cell in the exact same way. This suggests that while the genetic variant is associated with body mass index differences between men and women, it does not change the basic mechanical function of the receptor in the way the researchers initially hoped.
The findings indicate that while genetic differences between men and women likely exist and influence body weight, the specific genetic variant identified in this study does not appear to be the direct cause of different treatment responses through a simple change in receptor function. The researchers concluded that the link between this gene and body mass index in men is real, but the reason for it remains a mystery. It is possible that this genetic marker is simply standing in for another, unseen genetic factor, or that it influences the body in a more subtle way that was not captured by their lab tests. The study underscores the importance of looking at men and women separately in genetic research, as combining the data would have completely hidden the male-specific pattern they found. While this specific variant did not explain the differences in treatment success, the work highlights that sex is a critical factor in understanding the genetics of obesity, and future studies will need to continue separating the sexes to uncover the true reasons why some people respond better to weight loss therapies than others.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.